Company / CapEx per Share
Akebia Therapeutics, Inc. CapEx per Share History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2025
5-year range
$0.00 / $0.04
FY2021-FY2025
Trend
+663.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
CapEx per Share changed +663% YoY in FY2025, a notable deviation from the 8-year average annual change of +803%.
Based on SEC 10-K filings.
0.00 in FY2025 with a 10-year CAGR of +3.3%.
Improved from $0.00 to $0.00 over the past 2 years.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- -37.2%
- 10-Year CAGR
- +3.3%
Key checks
Key Insights
- In FY2025, capex per share increased 663.1% year-over-year.
- Peak capex per share was recorded in FY2018.
- Lowest capex per share in the period was in FY2023.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | +663.1% |
| FY2024 | $0.00 | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | -98.6% |
| FY2021 | $0.04 | +240.5% |
| FY2020 | $0.01 | -4.9% |
| FY2019 | $0.01 | -75.2% |
| FY2018 | $0.06 | +5894.3% |
| FY2015 | $0.00 | -93.2% |
| FY2014 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026